UPPER GASTROINTESTINAL SAFETY WITH THE BUFFERED SOLUTION OF ALENDRONATE 70 MG: POST-MARKETING EXPERIENCE

被引:0
|
作者
Hruska, J. [1 ]
Jorgensen, F. K. [2 ]
Pierleoni-Nielsen, C. [2 ]
Eriksen, E. F. [3 ]
机构
[1] McDACom GmbH, Zurich, Switzerland
[2] Klifo AS, Glostrup, Denmark
[3] Oslo Univ Hosp, Dept Clin Endocrinol, Oslo, Norway
关键词
OSTEOPOROSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P589
引用
收藏
页码:S366 / S366
页数:1
相关论文
共 50 条
  • [31] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    CHEMOTHERAPY, 2007, 53 (02) : 85 - 103
  • [32] A Pharmacovigilance Analysis of Post-Marketing Safety of Tezepelumab
    Li, Huqun
    Wang, Chongshu
    Guo, Cuilian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (03):
  • [33] POST-MARKETING SAFETY STUDIES Three design aspects for high quality post-marketing cohort studies
    Fralick, Michael
    Kesselheim, Aaron S.
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [34] Efficacy and tolerability of topiramate: Post-marketing experience
    Delanty, N
    French, JA
    Williams, SF
    NEUROLOGY, 1998, 50 (04) : A100 - A100
  • [35] Weight and consequences of post-marketing (-approval) experience
    Kreutz, G
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 : 90 - 91
  • [36] Post-marketing safety experience of vedolizumab in patients receiving concomitant treatment with other biologics
    Cohen, R. D.
    Bhayat, F.
    Blake, A.
    Travis, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S362 - S362
  • [37] Renal safety and tolerability of ibandronate in clinical practice:: German post-marketing experience.
    Seraphin, J.
    Schuetz, F.
    Nusch, A.
    Meden, H.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S63 - S64
  • [38] Post-marketing experience of vedolizumab for IBD: The University of Chicago experience
    Christensen, B.
    Goeppinger, S. R.
    Colman, R.
    Siddiqui, D.
    Yarur, A.
    Bochenek, A. A.
    Wichmann, A.
    Hirsch, A.
    Kinnucan, J.
    Sakuraba, A.
    Cohen, R.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S388 - S389
  • [39] POST-MARKETING SAFETY EXPERIENCE OF VEDOLIZUMAB IN PATIENTS RECEIVING CONCOMITANT TREATMENT WITH OTHER BIOLOGICS
    Cohen, Russell D.
    Bhayat, Fatima
    Blake, Aimee
    Travis, Simon P.
    GASTROENTEROLOGY, 2019, 156 (06) : S876 - S876
  • [40] Post-marketing safety experience of vedolizumab in patients with pre-existing viral hepatitis
    Wu, Deng-Chyang
    Hilmi, Ida Normiha
    Adsul, Shashi
    Blake, Aimee
    Bhayat, Fatima
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 126 - 126